Sectoral Asset Management’s Sage Therapeutics SAGE Stock Holding History

Sectoral Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7,800	Closed	-$324K	–	167
2020 Q2	$324K	Buy	+7,800	New	+$283K	0.03%	156
2020 Q1	–	Sell	-7,650	Closed	-$552K	–	69
2019 Q4	$552K	Sell	7,650 -2,850	-27%	-$351K	0.08%	64
2019 Q3	$1.47M	Sell	10,500 -13,900	-57%	-$2.33M	0.25%	57
2019 Q2	$4.47M	Sell	24,400 -7,200	-23%	-$1.23M	0.53%	55
2019 Q1	$5.03M	Sell	31,600 -5,500	-15%	-$796K	0.6%	57
2018 Q4	$3.55M	Hold	37,100	–	–	0.48%	53
2018 Q3	$5.24M	Hold	37,100	–	–	0.56%	52
2018 Q2	$5.81M	Buy	37,100 +4,500	+14%	+$706K	0.65%	47
2018 Q1	$5.25M	Buy	32,600 +15,400	+90%	+$2.61M	0.58%	55
2017 Q4	$2.83M	Buy	+17,200	New	+$1.67M	0.35%	52
2017 Q3	–	Sell	-12,199	Closed	-$972K	–	65
2017 Q2	$972K	Hold	12,199	–	–	0.11%	56
2017 Q1	$867K	Sell	12,199 -15,700	-56%	-$920K	0.1%	59
2016 Q4	$1.43M	Buy	+27,899	New	+$1.32M	0.16%	46
2016 Q3	–	Sell	-52,250	Closed	-$1.57M	–	60
2016 Q2	$1.57M	Sell	52,250 -368,834	-88%	-$12.3M	0.16%	54
2016 Q1	$13.5M	Buy	+421,084	New	+$14.8M	0.65%	40

Other funds holding SAGE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sectoral Asset Management's SAGE Position: Q3 2020 in Review

Sectoral Asset Management sold out of Sage Therapeutics (SAGE) in Q3 2020, closing a stake of 7,800 shares — an estimated $324K sold.

Sectoral Asset Management first reported a position in SAGE in Q1 2016 and held it in 15 quarters. The position peaked at $13.5M in Q1 2016. 231 funds tracked by Wall St. Rank hold SAGE as of Q3 2020.

Sectoral Asset Management reported no remaining Sage Therapeutics position as of Q3 2020 after selling out during the quarter.
Sectoral Asset Management sold 7,800 Sage Therapeutics shares in Q3 2020, an estimated $324K.
Sectoral Asset Management first reported a position in Sage Therapeutics in Q1 2016 and held it in 15 quarters.
Sectoral Asset Management's Sage Therapeutics position peaked at $13.5M in Q1 2016.
231 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2020.

Based on Sectoral Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.